Collectively, these experimental studies demonstrate that PAD4-dependent protein citrullination and NET formation do not act as a pathogenic mechanism in RA and SLE pathology in mice with A20 mutations, and likely not in individuals with A20 polymorphisms or mutations. Here, PADI4 is linked to rheumatoid arthritis.